Efforts to Develop Treatments for Bundibugyo Virus

In Mongbwalu, Democratic Republic of Congo, health workers are actively gathering medication for individuals suspected of having the Bundibugyo virus. This virus has recently prompted an outbreak in the area.

Trials are taking place to assess the effectiveness of several promising drugs. These trials aim to discover potential treatments for the virus that is currently affecting many individuals.

At an emergency Ebola treatment center in Rwampara, Democratic Republic of Congo, Dr. Papys Lame and his team provide essential care. They address symptoms such as severe diarrhea and vomiting, manage bleeding, and help those in respiratory distress. Their efforts represent a marked improvement compared to the resources available in previous outbreaks.

Dr. Lame, the Ebola response coordinator for the Alliance for International Medical Action, notes the advancements made: “Today we have more options, and more people survive.” However, a tailored treatment for the Bundibugyo virus remains elusive. The current outbreak in East Africa has infected at least 695 people and claimed 138 lives. Scientists are urgently searching for effective drugs.

Why are there no treatments for Bundibugyo virus?

Over five decades, most Ebola disease outbreaks have been caused by a different virus species, the Ebola virus. The World Health Organization recommends two drugs for Ebola virus treatment based on clinical trial outcomes. Nonetheless, a drug effective against one virus is not necessarily effective against another due to significant evolutionary differences.

A soldier in Mongbwalu is seen checking temperatures outside a hospital, a precautionary measure during this challenging time.